Merus

MRUS | NASDAQ | 0 Obserwujący

$56.07

+1.26%

$0.70

Obserwuj

Overview Metrics Financials

Fair Price

$77.24

Overvalued by 8.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Merus N.V. is a Dutch biotechnology company focused on developing innovative immunotherapies for cancer treatment. The company is particularly known for its bispecific antibody technology, designed to selectively activate the immune system against cancer cells. Merus N.V. concentrates on developing treatments that can offer new hope to patients suffering from various types of cancer, including those who have failed other therapies.

Feed

There are no posts to show right now.

Merus

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?